The increasing launch of effective drugs is a key factor driving the U.S. secondary hyperparathyroidism treatment market, says Fortune Business Insights in a report, titled “Secondary Hyperparathyroidism Treatment (SHPT) Market Size, Share & Industry Analysis, By Drug Class (Calcimimetics, Vitamin D Analogues, and Phosphate Binders), By Distribution Channel (Hospital & Retail Pharmacies, Online Channels, and Others) and Region Forecast, 2019-2026.” The secondary hyperparathyroidism treatment (SHPT) market was valued at USD 4.34 Billion in 2018 and is expected to reach USD 7.06 Billion by 2026, exhibiting a CAGR of 9.0%.
Emerging Guidelines By Government Authorities Will Boost Growth
The increasing government initiatives for improvising secondary hyperparathyroidism management will create growth opportunities for the secondary hyperparathyroidism treatment market. The aim of SHPT treatment is to manage the biochemical markers of bone and mineral metabolism, which are directly linked to cardiovascular events and bone fractures by extensive epidemiologic evidence. International & national organizations in the U.S. and working groups such as the National Kidney Foundation have published various clinical guidance documents to encourage best practices in managing SHPT. Furthermore, increasing awareness about SHPT in physicians, as well as clinical specialists, have improved the treatment regimen for its management. The improvement in earlier identification and assessment of SHPT for mineral metabolism in CKD & ESRD will have a positive impact on secondary hyperparathyroidism treatment market growth. The reduction in associated complications for the management of SHPT is expected to accelerate growth of the market during the forecast period.
Table of Content
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
- Key Insights
4.1 Prevalence of Secondary Hyperparathyroidism, 2018
4.2 Distribution of Secondary Hyperparathyroidism Patients by Treatment Type – Surgery, Drugs and Others, 2018
4.3 Key Industry Developments – Mergers, Acquisitions and Partnerships
4.4 Pipeline Analysis
4.5 Reimbursement Scenario
4.6 Cost Burden of Secondary Hyperparathyroidism
- U.S. Secondary Hyperparathyroidism Treatment Market Analysis, Insights, and Forecast, 2015-2026
5.1. Market Analysis, Insights, and Forecast – By Drug Class
5.1.2 Vitamin D Analogues
5.1.3 Phosphate Binders
5.2. Market Analysis, Insights, and Forecast – By Distribution Channel
5.2.1 Hospital & Retail Pharmacies
5.2.2 Online Pharmacies
5.3. Market Analysis, Insights, and Forecast – By Region
- Competitive Analysis
6.1. Key Industry Developments
6.2. U.S. Market Share Analysis (2018)
6.3. Competition Dashboard
6.4. Comparative Analysis – Major Players
6.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
6.5.1 Teva Pharmaceutical Industries Ltd.
6.5.2 Genzyme Corporation (Sanofi)
6.5.3 AbbVie Inc.
6.5.4 Cipla Inc.
6.5.5 Dr. Reddy’s Laboratories Ltd.
6.5.6 Amgen Inc.
6.5.7 OPKO Health, Inc.
- Strategic Recommendations
Highlights of the Report
- In-depth analysis of various insights, namely, Secondary Hyperparathyroidism Treatment Market trends, growth drivers, opportunities, and other related challenges.
- Comprehensive details of key market players, their core competencies, and market shares.
- The potency of suppliers and buyers to make better business decisions.
- Lists out the market size in terms of volume.
KEY QUESTIONS ANSWERED:
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?
More Trending Topics From Fortune Business [email protected]